Fig. 5From: Patient-specific image-based bone marrow dosimetry in Lu-177-[DOTA0,Tyr3]-Octreotate and Lu-177-DKFZ-PSMA-617 therapy: investigation of a new hybrid image approachComparison of bone marrow absorbed doses from the ROB and total bone marrow absorbed doses as calculated via the reference protocol and the HP24, HP48, and HP72 (24, 48, or 72Â h p. i.)Back to article page